Preparation, Characterization, and Preliminary Imaging Study of [<sup>188</sup>Re]Re-Ibandronate as a Novel Theranostic Radiopharmaceutical for Bone Metastasis.

Contrast Media Mol Imaging · 2022 · PMC8896928 · PMID 35280705

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

However, the dose of 37 MBq was too high for mice, and the body weight of this group still showed an increasing trend, and the pathological results were not abnormal, suggesting that [ 188 Re]Re-IBA is safe and has low toxicity. 3.5.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.